Dan Groman - Feb 17, 2023 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
Chief Technology Officer
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Stock symbol
ENFN
Transactions as of
Feb 17, 2023
Transactions value $
-$42,376
Form type
4
Date filed
2/22/2023, 03:22 PM
Previous filing
Jan 27, 2023
Next filing
Mar 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Sale -$42.4K -3.88K -4.14% $10.93 89.9K Feb 17, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2022.